Last month, the FDA sent a warning letter to manufacturers and marketers of dietary supplements that it will be targeting the hundreds of products that contain drugs or chemicals that function like drugs. Unlike prescription drugs, which must … [Read more...]
Darvon, Darvocet Withdrawn from US Market
After reviewing new data demonstrating that the painkiller propoxyphene (marketed as Darvon and Darvocet) significantly increases the risk of possibly fatal heart arrhythmia, the FDA has requested Xanodyne Pharmaceuticals and other companies making … [Read more...]
FDA Severely Restricts Avandia
On September 23rd, the FDA announced severe restrictions to be placed on GlaxoSmithKline’s controversial diabetes drug Avandia. These restrictions make Avandia an option only for patients with Type 2 diabetes who cannot use other medications to … [Read more...]
FDA Reviews Actos for Bladder Cancer Risk
The federal Food and Drug Administration (FDA) announced Friday that it is reviewing Takeda Pharmaceuticals' diabetes drug Actos due to concerns that the drug increases the risk of bladder cancer in patients who take it over a long period of time. … [Read more...]
Accutane Verdict Reversal Favorable To Roche
Roche Holding AG, the maker of the acne drug, Accutane, has won a reversal of a $10.5 million verdict because a judge barred the company from using evidence about the drug’s use. Lawyers for Roche should have been able to use data about how many … [Read more...]
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »